Closed CDC-RFA-PS23-2302 CFDA 93.116 Discretionary

Accelerating the Prevention and Control of HIV, Viral Hepatitis, STDs, and TB in the U.S. Affiliated Pacific Islands

Posted by Centers for Disease Control - NCHHSTP

Opportunity snapshot. This Grants.gov announcement — Accelerating the Prevention and Control of HIV, Viral Hepatitis, STDs, and TB in the U.S. Affiliated Pacific Islands — is cataloged under number CDC-RFA-PS23-2302 and tied to CFDA assistance listing 93.116, posted by Centers for Disease Control - NCHHSTP. Grants.gov currently shows the opportunity as closed, first posted on May 24, 2022. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is Varies by applicant. The agency has projected $19.5 million in total estimated funding for this announcement. It expects to issue 6 awards. If the agency funds the expected 6 awards from the $19.5 million estimated pool, the average award works out to roughly $3.3 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on July 31, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully — federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed — it helps clarify scope and scoring priorities.

Award Range

Varies by applicant

Close Date

July 31, 2022

Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Posted

May 24, 2022

Est. Total Funding

$19,500,000

Expected Awards

6

Instrument

Cooperative Agreement

Description

The U.S. Affiliated Pacific Islands (USAPI) are comprised of the three U.S. territories of American Samoa, the Commonwealth of the Northern Mariana Islands, and Guam, as well as the three sovereign nations of the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. The public health care systems in these remote islands require assistance to improve the infrastructure, capacity, and local expertise to prevent HIV in high-risk populations and to effectively address the high burden of sexually transmitted diseases (STDs), tuberculosis (TB), and viral hepatitis (VH) in their jurisdictions. Additionally, laboratory capacity is limited, surveillance systems are fragmented, and provision of health care is challenging and costly due to the vast geographic distances and broadly dispersed population throughout islands across the Pacific Ocean. This integrated Notice of Funding Opportunity (NOFO) is supported by the National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) and aims to: Promote program collaboration and services integration to capitalize on the opportunity to prevent , diagnose, and treat HIV, STD, TB, and VH. Improve collection, sharing, reporting, analysis, interpretation, and use of surveillance and other program data. Assure implementation of policies and plans that will make effective use of resources to improve health outcomes. Develop the public health care workforce through training and education. Improve public health laboratory capacity. Enhance prevention, care, follow-up and treatment for disease-specific activities. Reduce administrative burdens of managing multiple cooperative agreements by consolidating the application and award process as well as streamlining the reporting requirements.

Eligibility

00;01;02;04;05;06;07;08;11;12;13;20;22;23;25;99

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Tamika Hoyte<br/>thoyte@cdc.gov

Key Dates

Posted May 24, 2022
Close Date July 31, 2022
Archive Date August 30, 2022
Last Updated May 24, 2022

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Accelerating the Prevention and Control of HIV, Viral Hepatitis, STDs, and TB in the U.S. Affiliated Pacific Islands", offered by Centers for Disease Control - NCHHSTP. It is associated with CFDA program 93.116. The U.S. Affiliated Pacific Islands (USAPI) are comprised of the three U.S. territories of American Samoa, the Commonwealth of the Northern Mariana Islands, and Guam, as well as the three sovereign na...
Is this opportunity still open?
No, this opportunity is closed. It closed on July 31, 2022. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant. Total estimated funding: $19,500,000. Expected number of awards: 6.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainGrants Editorial